Related Experiment Videos

[Can the prognosis of rheumatoid arthritis be improved by medication?]

¹Keski-Suomen keskussairaala, sisätautiyksikkö, Jyväskylä, Finland.

Duodecim; Laaketieteellinen Aikakauskirja

|January 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Limited reduction of bone mineral density in patients with early rheumatoid arthritis receiving aggressive treatment: 10 year results of the NEO-RACo study.

Scandinavian journal of rheumatology·2025

Three out of four disease-modifying anti-rheumatic drug-naïve rheumatoid arthritis patients meet 28-joint Disease Activity Score remission at 12 months: results from the FIN-ERA cohort.

Scandinavian journal of rheumatology·2017

Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial.

Scandinavian journal of rheumatology·2012

Anti-citrullinated peptide antibodies and the progression of radiographic joint erosions in patients with early rheumatoid arthritis treated with FIN-RACo combination and single disease-modifying antirheumatic drug strategies.

Clinical and experimental rheumatology·2011

A mismatch between self-reported physical work load and the HAQ: early identification of rheumatoid arthritis patients at risk for loss of work productivity.

Clinical and experimental rheumatology·2009

Rituximab therapy in patients with rheumatoid arthritis refractory or with contraindication to anti-tumour necrosis factor drugs: real-life experience in Finnish patients.

Scandinavian journal of rheumatology·2009

See all related articles